#U.S. Veterinary Vaccines Market Analysis

[kathansky]

Global Animal Health Market: Size, Share, Growth, Industry Trends | 2024-2031

Leading market research firm SkyQuest Technology Group recently released a study titled 'Animal Health Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Animal Health report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Animal Health Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

The research analysis on the global Animal Health Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Animal Health Market circumstances in the forecast period between 2024 and 2031. The global Animal Health Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Animal Health Market has experienced robust growth over the past decade and is projected to continue expanding. Global Animal Health Market size was valued at USD 58.28 billion in 2022 and is poised to grow from USD 63 billion in 2023 to USD 117.48 billion by 2031, at a CAGR of 8.1% over the forecast period (2024- 2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/animal-health-market 

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Animal Health Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Animal Type

Production Animals (Poultry, Swine, Cattle, Sheep & Goats, Fish), Companion Animal (Dog, Cat, Horse, Others)

Product

Biologics (Vaccines [Modified/ Attenuated Live,Inactivated(Killed), Other Vaccines], Other Biologics), Pharmaceuticals (Parasiticides, Anti-Infectives, Anti -Inflammatory, Analgesics, other), Medicinal Feed Additives, Diagnostics (Consumables, Reagents and Kits,Instruments and Devices), Equipment & Disposables (Critical care Consumables, Anesthesia equipment, Temprature Management Equipment, Rescue & Resuscitation Equipment, Research Equipment, Patient Monitoring Equipment), Others (Veterinary Telehealth, Veterinary Software, Livestock Monitoring)

Distribution Channel

Retail, E-Commerce, Hospital/Clinic Pharmacy

End Use

Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics and Others

Get your customized report @ https://www.skyquestt.com/speak-with-analyst/animal-health-market 

Following are the players analyzed in the report:

Zoetis Inc. 

Merck Animal Health 

Elanco Animal Health 

Boehringer Ingelheim Animal Health 

Bayer Animal Health 

Virbac 

Ceva Santé Animale 

IDEXX Laboratories, Inc. 

Vetoquinol S.A. 

Dechra Pharmaceuticals PLC 

Neogen Corporation 

Phibro Animal Health Corporation 

Kindred Biosciences, Inc. 

Norbrook Holdings Limited 

Heska Corporation 

Nutreco N.V. 

AniCura AB 

PetIQ, Inc. 

Idexx Laboratories 

Petmed Express, Inc.

Regional Analysis 1. North America: - The United States and Canada dominate the North American Animal Health Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Animal Health consumption. 2. Europe: - Europe is a significant player, with major Animal Health Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Animal Health manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Animal Health Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Animal Health Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

Buy your full report: https://www.skyquestt.com/buy-now/animal-health-market 

[industrynewsupdates]

Biopreservation Market Size, Share, Growth Analysis And Forecast, 2030

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment

o Freezers

o Refrigerators

o Consumables

o Vials

o Straws

o Microtiter Plates

o Bags

o Liquid Nitrogen

• Media

o Pre-formulated

o Home-brew

• Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Regenerative Medicine

o Cell Therapy

o Gene Therapy

o Others

• Bio-banking

o Human Eggs

o Human Sperms

o Veterinary IVF

• Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

• The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

• Azenta US, Inc.

• Biomatrica, Inc.

• BioLife Solutions

• MVE Biological Solutions

• LabVantage Solutions, Inc.

• Taylor-Wharton.

• Thermo Fisher Scientific, Inc.

• Panasonic Corporation

• X-Therma Inc.

• PrincetonCryo.

• Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[trendingreportz]

DNA Vaccines Market - Forecast(2024 - 2030)

 DNA Vaccines Market is forecast to reach revenue of $9.43 Billion by 2025, growing at a CAGR of 33.86% during the forecast period 2020-2025. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulates a wider range of immune responses in the body with few side effects. DNA based Vaccines concept deliver to cells after which the gene is expressed and can generate the protein of interest. Clinical trials of some DNA vaccines have shown promising results in the treatment of several types of cancers like metastatic melanoma, prostate carcinoma, pancreatic cancer, and other solid tumors. The demand for DNA Vaccines is experiencing rapid growth owing to factors such as adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals and others. With the rise of COVID-19 pandemic throughout the world 

Request Sample

Key Takeaways

North America dominates the DNA Vaccines Market owing to the increasing prevalence of infectious diseases in countries such as U.S and Canada.

Adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals are some of the key factors which are leading the demand for DNA Vaccines.

With the current COVID-19 Outbreak there is a huge demand for vaccination that can hack to build better immunity in order to fight the virus

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the DNA Vaccines Market.

By Type – Segment Analysis 

Based on the types, the DNA Vaccines Market is segmented into Human DNA Vaccines and Animal DNA Vaccines. Animal DNA vaccine is dominating the market in 2019 and is estimated to grow at a CAGR of 19.8% during the forecast period 2020-2025. This is owing to the unavailability of human DNA vaccines in the market along with the rising incidence of canine melanoma and other animal diseases. Animal vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into host body and produces protein for which the body generates immune response. Moreover, the strong pipeline of human targeted vaccines is likely to aid in the market growth

Inquiry Before Buying

By Application – Segment Analysis

Based on the applications, DNA Vaccines Market is segmented into Human Diseases which includes applications in Oncology, Infectious Disease, Allergies, and Veterinary Disease. The Veterinary Disease based on application is forecast to grow at a higher CAGR during the forecast period 2020-2025 owing to availability of DNA vaccines for animal diseases that includes canine melanoma vaccine (DOG), West Nile Innovator (Horse), Life tide-SW5 (Swine and other food animals) and Apex-IHN (Salmon fish). 

By Geography – Segment Analysis

Based on the geography the DNA Vaccines Market has covered globally viz North America, South America, Europe, Asia Pacific (APAC) and Rest of World (ROW). The Market in North America accounts for 43.7% of the total market share, which is attributed by government initiatives to immune citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. 

Asia Pacific region is set to be the highest growth during the forecast period 2020-2025 owing to rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B. Additionally, it is estimated that the DNA Vaccines Market is set to grow exponentially during the forecast period 2020-2025 owing to COVID-19 outbreak.

Schedule a Call

Market Drivers - DNA Vaccines Market

Rising Demand for effective treatment of infectious disease in driving market

DNA Vaccines used to kill and stop the growth of microorganisms. These drugs can act as a defense system for the human body and neutralize the action of disease causative agents. With increasing research activities and Increasing awareness and extensive R&D drugs, there is rising demand for treatment of infectious diseases

Challenges - DNA Vaccines Market

The main area of uncertainty is related to the immunological impact, tissue distribution and persistence after injection and whether the DNA vaccine can leak into the environment. This, in turn, create a challenging point for the growth of DNA Vaccine. Also, with, the limited efficiency of plasmid-based techniques precluded their use in the creation of more accurate human cell models is one of the challenges for DNA Vaccine Market

Buy Now

Vitamin & Mineral Industry Outlook

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the DNA Vaccines Market. In 2019, DNA Vaccines Market share is consolidated by the top ten players present in the market. DNA Vaccines Market Top 10 companies include Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals GlaxoSmithKline Corp, Protein Sciences Corp.among others.

Acquisitions/Product Launches

In February 2020, Merck& Co announced the formation of a new, independent publicly-traded company focused on its Women’s Health, trusted Legacy Brands, and Biosimilars business. 

In February 2019, Merck & Co announced its acquisition of Immune Design Corp for nearly $300 million, gaining access to its immunotherapy programs.

[shubhampawrainfinium]

"Veterinary Animal Vaccines: Genuine Market Growth or Just a Shot in the Dark?"

Introduction

Veterinary or animal vaccines play a crucial role in maintaining animal health and preventing the spread of infectious diseases among livestock and pets. These vaccines are essential for improving animal welfare, enhancing productivity, and ensuring food safety in agricultural practices. The market for veterinary vaccines is driven by increasing awareness of animal health, growing demand for livestock products, and advancements in vaccine technology. This report provides a detailed analysis of the veterinary vaccines market, including market dynamics, regional trends, segmentation, competitive landscape, and future outlook.

Market Dynamics

Drivers

Rising Animal Health Awareness: Growing awareness about the importance of preventive measures for animal health drives the demand for veterinary vaccines. Livestock producers and pet owners are increasingly prioritizing vaccination to prevent diseases and ensure animal well-being.

Increasing Demand for Animal Products: The global demand for meat, dairy, and other animal products is rising, leading to a greater focus on maintaining healthy livestock. Vaccines are crucial for preventing outbreaks of diseases that can affect animal productivity and food safety.

Advancements in Vaccine Technology: Innovations in vaccine development, such as recombinant and DNA-based vaccines, are improving efficacy and safety. Technological advancements are expanding the range of available vaccines and enhancing their effectiveness.

Challenges

High Costs: The development, production, and distribution of veterinary vaccines involve significant costs. High prices can limit access, particularly in developing regions where resources are constrained.

Regulatory Hurdles: Veterinary vaccines must adhere to stringent regulatory requirements across different countries. Navigating complex regulatory landscapes and obtaining approvals can be time-consuming and costly.

Vaccine Hesitancy: There is some resistance to vaccination in both livestock and pet owners due to concerns about safety and efficacy. Addressing these concerns through education and outreach is essential for increasing vaccine uptake.

Opportunities

Growth in Emerging Markets: Rapid urbanization and rising incomes in emerging markets are driving demand for animal health products, including vaccines. Expanding into these markets offers significant growth potential for vaccine manufacturers.

Innovation in Vaccine Development: Continued research and development in vaccine technology present opportunities for creating more effective and affordable vaccines. Innovations such as multivalent vaccines and improved delivery systems can address emerging health challenges.

Increased Focus on Disease Prevention: A growing emphasis on disease prevention and biosecurity measures in animal husbandry is driving the demand for vaccines. This trend is particularly relevant in regions with high livestock densities and disease prevalence.

Sample Pages of  Report: https://www.infiniumglobalresearch.com/reports/sample-request/1054

Regional Analysis

North America: The North American market is well-established, with high demand for veterinary vaccines driven by advanced animal health practices and stringent regulations. The U.S. and Canada are major markets, with a strong focus on both livestock and companion animal health.

Europe: Europe has a mature veterinary vaccine market with a high level of regulatory oversight and strong consumer awareness. The demand for vaccines is driven by both agricultural and companion animal sectors, with a growing emphasis on disease prevention and control.

Asia-Pacific: The Asia-Pacific region is experiencing significant growth due to increasing livestock production and rising incomes. Countries like China and India are key markets, with expanding veterinary healthcare infrastructure and growing awareness of animal diseases.

Latin America: In Latin America, the veterinary vaccine market is growing due to increasing livestock production and investments in animal health. Brazil and Argentina are prominent markets, with a focus on controlling diseases in both livestock and pets.

Middle East & Africa: The market in the Middle East and Africa is developing, with rising demand for veterinary vaccines driven by growing livestock industries and improving animal health practices. However, the market is still in its early stages compared to other regions.

Market Segmentation

By Type:

Companion Animal Vaccines

Livestock Vaccines (Cattle, Poultry, Swine, Sheep & Goats)

Aquaculture Vaccines

Others

By Technology:

Inactivated Vaccines

Live Attenuated Vaccines

Recombinant Vaccines

DNA/RNA Vaccines

Others

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Competitive Landscape

Market Share of Large Players: Major companies in the veterinary vaccines market, such as Zoetis Inc., Merck & Co., and Elanco Animal Health, hold significant market shares due to their extensive product portfolios, global presence, and strong research capabilities.

Price Control: Large players have some control over pricing due to their scale and established market presence. However, competition is strong, with pricing influenced by factors such as vaccine type, technology, and regional market dynamics.

Competition from Small and Mid-Size Companies: Smaller and mid-size companies challenge larger players by offering niche or innovative vaccines. These companies often focus on specialized vaccines for emerging diseases or specific animal health needs.

Key Players:

Zoetis Inc.

Merck & Co., Inc.

Elanco Animal Health

Boehringer Ingelheim

Bayer Animal Health

Report Overview: https://www.infiniumglobalresearch.com/reports/global-veterinary-animal-vaccines-market

Future Outlook

New Product Development: Innovation in vaccine development is crucial for addressing emerging diseases and improving vaccine efficacy. Companies that invest in research and development are likely to gain a competitive edge and drive market growth.

Sustainability: The emphasis on sustainability in animal agriculture is influencing vaccine development and production practices. Vaccines produced with environmentally friendly methods and those contributing to sustainable animal health practices are likely to resonate with stakeholders and drive future growth.

Conclusion

The veterinary vaccines market is poised for growth, driven by increasing awareness of animal health, rising demand for animal products, and advancements in vaccine technology. While challenges such as high costs and regulatory hurdles exist, opportunities in emerging markets and innovation present significant potential for expansion. Companies that focus on new product development and sustainability are well-positioned to succeed in this evolving industry, meeting the growing needs of both livestock and companion animal health.

[secretofresearch]

Veterinary Services Market is Estimated to Witness High Growth

The veterinary services market involves a wide range of important medical services for animals including preventive care, medication, surgeries and other treatment procedures. Regular veterinary exams help monitor animal health and detect problems early. Veterinary professionals also play a key role in disease prevention through vaccination programs. Emerging technologies are revolutionizing veterinary treatment with treatments such as regenerative medicine gaining popularity.

The global veterinary services market is estimated to be valued at US$ 130.16 billion in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the veterinary services are Fagron Sterile Services US, New Drug Loft & VLS Pharmacy, Nora Apothecary, Lifecare Pharmacy, Avella Specialty Pharmacy, Triangle Compounding Pharmacy, O€TMBrien Pharmacy, Tache Pharmacy, Northmark Pharmacy, Edge Pharma, and ImprimisRx. The veterinary services market presents significant opportunities owing to rising pet ownership globally and increasing per capita spending on pet care. Technological advancements are also supporting market growth with emerging therapies such as regenerative medicine gaining popularity for conditions which were earlier untreatable.

The key opportunities in the Veterinary Services Market Demand include rising penetration in developing countries with growing pet adoption, opportunities for multi-specialty services with urbanization and nuclear families, and scope for preventive healthcare programs. Technological innovation is a key enabler in the market with emerging technologies such as regenerative medicines, biologics and stem cell treatment impacting disease management.

Market drivers

One of the key drivers for the veterinary services market is growing pet population globally coupled with rising pet care expenditure. Pet humanization trends have significantly increased spending on pet food, healthcare, insurance and accessories. According to the latest APPA National Pet Owners Survey, U.S. pet industry expenditure reached a record $103.6 billion in 2019, with over $31 billion spent on veterinary care. Growing pet ownership and increasing willingness to spend on pet healthcare is a major market driver.

Current challenges in the Veterinary Services Market:

The veterinary services market is facing several challenges currently. One of the major challenges is the shortage of veterinarians globally. There is currently an unmet demand for veterinary care due to lack of sufficient veterinary professionals. This leads to delay in delivery of care. Another challenge is rising veterinary care costs. The costs associated with veterinary medicine and surgeries have increased significantly over the years. This pressure on budgets restricts access to quality care for many pet owners. Lack of awareness among pet owners regarding veterinary preventive healthcare is also a challenge. Many pet owners only seek treatment when their pet falls sick rather than focusing on preventive healthcare checkups. This affects timely diagnosis and treatment.

SWOT Analysis

Strength: Strong bond between veterinarians and pet owners leads to loyalty; Growing pet humanization trend boosts demand.

Weakness: Shortage of vets causes delay in care; Higher costs restrict broader access to care.

Opportunity: Rising pet adoption during COVID drives future growth; Scope for preventive healthcare awareness programs.

Threats: Threat from illegal or unqualified Veterinary Services Market Analysis offering low-cost services; Risk of new pet diseases and virus outbreaks.

Geographical Regions

North America dominated the veterinary services market in terms of value in the historical period due to high pet ownership and growing expenditure on pet care in countries like the US and Canada. Asia Pacific is expected to be the fastest growing region during the forecast period driven by factors like rising affluence, nuclearization of families and increasing awareness about animal health in major countries.

The United States represents the most concentrated geographical region for the veterinary services market currently. Within the country, states like California, Texas and New York have emerged as major hubs for both veterinary practices and companion animal care expenditures. Other developed countries within North America and Western Europe also exhibit high demand density due to high pet ownership.

Get more insights on Veterinary Services Market

About Author:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[marketwire]

Disposable Syringes Market - Forecast(2024 - 2030)

Disposable Syringes Market Overview:

Disposable Syringes Market size is estimated to reach $24 billion by 2030, growing at a CAGR of 6.7% during the forecast period 2023-2030. The rising demand for injectable medications and increasing adoption of telemedicine are propelling the Disposable Syringes Market growth.

Additionally, the education and training programs for healthcare providers and end-users on the proper use, handling and disposal are creating substantial growth opportunities for the Disposable Syringes Market. As per U.S. Bureau of Labor Statistics, health education specialists and community health workers are expected to grow at a significant rate of 12% by 2031, exceeding the average growth rate for all occupations. This reflects the increasing demand for these professionals and underscores their crucial role in advancing public health and wellness. These factors positively influence the Disposable Syringes industry outlook during the forecast period.

Market Snapshot:  Disposable Syringes Market - Report Coverage:

The “Disposable Syringes Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Disposable Syringes Market.

Attribute

Segment

By Type

Safety Syringes

Conventional Syringes

Prefilled Syringes

Insulin Syringes

Others

By Syringe Size

Below 5ml

5-10ml

Above 10ml

By Application  

Therapeutic Injections

Immunization Injections

Blood Sample Collection

Others

By End-User

Diagnostics Laboratories

Hospital

Pharmaceutical Industry

Blood Banks

Veterinary

Others

By Geography

North America (U.S., Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific)

South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

Rest of the World (Middle East and Africa).

 

COVID-19 / Ukraine Crisis - Impact Analysis:

●        The COVID-19 pandemic has created a heightened demand for disposable syringes due to the urgent need for vaccination campaigns worldwide. Vaccination programs require massive quantities of syringes for administering vaccines, which has resulted in increased production and sales of disposable syringes.

●        The Ukraine crisis has disrupted the supply chain of disposable syringes, including procurement of raw materials, manufacturing and distribution. This can result in challenges in the availability and accessibility of disposable syringes, potentially leading to supply shortages and production delays.

Key Takeaways:

●        Fastest Growth of Rest of the World : Geographically, in the global Disposable Syringes Market share, Rest of the World is analyzed to grow with the highest CAGR of 7.3% during the forecast period 2023-2030. The growth is attributed to the rising healthcare expenditure and infrastructure development in emerging economies. Moreover, the increasing prevalence of chronic diseases and the growing demand for injectable medications are also fueling the market. In November 2021, Revital Healthcare (EPZ) Limited, a Kenyan medical supply manufacturer, announced that it had received nearly $4 million from the Bill & Melinda Gates Foundation to expand the production of auto-disable vaccine syringes. This funding allowed Revital to increase syringe production volume from approximately 72 million.

●        Therapeutic Injections is Leading the Market : According to the Therapeutic Injections Market forecast, the Therapeutic Injections held the largest market valuation of $5.9 billion in 2022 owing to the increasing prevalence of chronic diseases, rising demand for injectable medications and advancements in therapeutic treatments. Therapeutic injections are commonly used for administering medications for conditions such as diabetes, cancer, autoimmune diseases and others.

●        Prefilled Syringes to Register the Fastest Growth : In the Disposable Syringes Market analysis, the Prefilled Syringes segment is estimated to grow with the highest CAGR of 7.2% during the forecast period. The increasing demand for efficient and convenient drug delivery systems drives the adoption of prefilled syringes. These syringes come pre-loaded with a precise dosage of medication, eliminating the need for manual filling and reducing the risk of dosing errors. In May 2022, Terumo Corporation introduced a pre-fillable polymer syringe designed for low-dose applications. This innovative product provides a safe, user-friendly, and efficient treatment solution, catering to the needs of healthcare professionals and patients alike.

●         Adoption of  Injectable Medication : The demand for injectable medications is on the rise due to the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases and the growing aging population as well as advancements in therapeutic treatments. Injectable medications are preferred for their fast and effective delivery, precise dosing and ease of administration. In 2022, as per Drug Development & Delivery article, the growth of the injectable drug delivery is projected reach of $83.38 billion by 2030 which demonstrates the rising demand for efficient and convenient administration of medication through injectable routes.

●        Increasing Adoption of Telemedicine : Telemedicine enables patients to consult with healthcare professionals remotely, facilitating remote diagnosis, monitoring and prescription of medications. Disposable syringes play a crucial role in facilitating safe and convenient self-administration of injectable medications for chronic diseases like diabetes and autoimmune disorders. Syringes with their convenience, ease of use and disposable nature have become an essential tool in the telemedicine ecosystem which is driving the demand and growth of the market. In 2022, according to the NCBI report, over 57% of individuals aged 0-17 showed a high inclination towards using telehealth services and indicating a strong willingness among younger individuals to adopt telemedicine.

●        High Cost and Affordability Hamper the Market Growth : Expensive production processes, raw material costs and pricing limit accessibility, especially in resource-constrained settings and pose challenges for patients, healthcare providers and healthcare systems in procuring and using disposable syringes.This factor impedes the Disposable Syringes market growth.

Disposable Syringes Market Share (%) By Region, 2022

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Disposable Syringes Market. The top 10 companies in this industry are listed below:

Baxter International Inc. (BD® 60 mL Luer syringes)

Medtronic plc (i-Port AdvanceTM)

Fresenius Kabi AG (Amicus® Extracorporeal)

Terumo Corporation (PLAJEX™ COP,  Safe'n'Sound®)

B. Braun SE (Original Perfusor® Syringes, Omnifix® Lock)

Becton, Dickinson and Company. (Ultra-Fine™, Safety-Glide™)

Novo Nordisk A/S (FlexPen®, NovoPen® 5)

Retractable Technologies, Inc. (VanishPoint®, Patient Safe®)

Henke-Sass, Wolf GmbH (HSW HENKE-JECT®– two-part, HSW HENKE-JECT® Insulin)

Nipro Corporation (Dual chamber bags PLW®, Pre-filled syringes [PFS®])

Scope of the Report: 

Report Metric

Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

6.7%

Market Size in 2030

$24 billion

Segments Covered

Type, Syringes Size, Application, End-User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

            Baxter International Inc.

            Medtronic plc

            Fresenius Kabi AG

            Terumo Corporation

            B. Braun SE

            Becton, Dickinson and Company.

            Novo Nordisk A/S

            Retractable Technologies, Inc.

            Henke-Sass, Wolf GmbH

            Nipro Corporation

For more Lifesciences and Healthcare Market reports, please click here

[researchnreports]

Aquatic Veterinary Treatment Market Share, Size, Growth, Opportunities and Forecast to 2030

The Insight Partners offers investors a comprehensive study of the Aquatic Veterinary Treatment market from the perspective of entrepreneurs in their most recent research report, " Aquatic Veterinary Treatment Market Share, Size and Trends Analysis | 2030" Examining current market conditions yields insightful information for businesses.

This report provides insights into market possibilities, obstacles, and incentives that companies shouldn't pass up. It would be a company recipe for success to choose a Aquatic Veterinary Treatment market research since consumer-centric firms often provide higher returns on investment. Making a small batch of items won't be enough, given the intense competition in the Aquatic Veterinary Treatment market. Businesses may estimate a product's potential and success with the use of market research.

The study is perhaps a perfect mixture of qualitative and quantitative information highlighting key market developments, challenges, and competition the industry faces alongside gap analysis and new opportunities available and trends within the market. The Aquatic Veterinary Treatment market report offers market size, recent trends, growth, share, development status, government policy, market dynamics, cost structure, and competitive landscape. The research report also includes the present market and its growth potential in the given period of forecast.

At the heart of our success lies a commitment to rigorous and reliable methodologies. The firm employs a combination of quantitative and qualitative approaches, ensuring a holistic understanding of Aquatic Veterinary Treatment market analysis dynamics. This includes:

Primary Research: In-depth interviews and surveys with key industry stakeholders provide firsthand insights into Aquatic Veterinary Treatment market trends and challenges.

Data Analytics: Advanced data analytics tools and techniques are utilized to process large datasets, uncovering patterns and correlations that might otherwise go unnoticed in calculating the Aquatic Veterinary Treatment market size.

Expert Analysis: A team of seasoned analysts with diverse industry expertise meticulously analyzes data to draw actionable conclusions and provide strategic recommendations about the Aquatic Veterinary Treatment market forecast.

Key companies in the Aquatic Veterinary Treatment market are- Merck & Co. Inc., Zoetis LLC, HIPRA, Phibro Animal Health Corp, Boehringer Ingelheim Animal Health, Nisseiken Co. Ltd., VETERQUIMICA S.A., Elanco Animal Health Inc., Microsynbiotix, AquaTactics Fish HealthOn the Basis of Treatment this market is categorized further into-

Vaccines

Medications

and Supplements

On the Basis of Species this market is categorized further into-

Fish

Crustaceans

Mollusca

and Others

On the Basis of Disease Source this market is categorized further into-

Bacterial

Viral

Parasites

and Others

On the Basis of Route of Administration this market is categorized further into-

Water Medication

Medicated Feed

and Others

Key regions Aquatic Veterinary Treatment Market Research Report:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World

This report is an essential resource for businesses seeking to stay ahead of the competition in the Aquatic Veterinary Treatment market. With its comprehensive analysis of recent developments and emerging trends, it provides valuable insights into the market that can be used to develop effective growth strategies and improve market positioning. The report aims to provide readers with a comprehensive overview of the market analyses. Its objective is to aid readers in devising business growth strategies, assessing the competitive landscape, evaluating their position in the current Aquatic Veterinary Treatment market, and making well-informed business decisions. The report presents several market projections for crucial variables such as market size, manufacturing, revenue, consumption, CAGR, gross margin, and price.

How can this research help you in getting business strategically correct?

Exact valuation and key facts about the market | 2030

Value proposition analysis that helps businesses revise their offerings timely

Marketing and segmentation strategies for new entrants in the market

Competitive Aquatic Veterinary Treatment market growth strategies for market participants

Latest trends and technologies in the market

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

[latestindustryreports]

Veterinary Vaccines Market Growth with Worldwide Industry Analysis

The latest market research released by The Insight Partners- “Growth Projections on Veterinary Vaccines Market - Statistics and Facts” is the one-stop solution for all Veterinary Vaccines market-related queries. Companies willing to excel in the competitive Veterinary Vaccines market are foreseen to face some challenges. This report offers a thorough picture of those challenges to prepare businesses to tackle them in the forecast period. This meticulous research is the result of primary and secondary research methods. Investor's viewpoints have been taken into consideration while integrating the scope for products and services in the forecast period. This report presents an unbiased analysis of the Veterinary Vaccines market to help companies make informed decisions.

Veterinary Vaccines Market Dynamics Analysis

The supply and demand curves are impacted by market dynamics; therefore, policymakers have to figure out how to effectively employ different financial tools to heat up or cool down the Veterinary Vaccines market. Our analysts offer unbiased views on the current market situation. This section further includes a forecast of the forces that are likely to influence on prices and behaviors of consumers and manufacturers. In the Veterinary Vaccines market, forces shape price policies and may result in the fluctuation of supply and demand for products. This further delves into supply-side economics to determine the growth potential for Veterinary Vaccines market participants.

Competitive Veterinary Vaccines Market Landscape

In a highly competitive space, companies need to keep discovering new products and features. This chapter on competitive analysis will offer ways in which companies can improve their customer journey. Knowing the advantages and disadvantages of your rivals is a necessary component of comprehending the competitive environment. By learning from an analysis like this, the business can better position itself in the market and comprehend how others have achieved success.

Key companies in this market are- Boehringer Ingelheim International GmbH, MERCK, Zoetis Services LLC, Elanco, Vetoquinol, Ceva, Virbac, NEOGEN Corporation, Biovac, ImmuCell Corporation

Veterinary Vaccines market research report, which contains proof of findings and provides the best opportunity for businesses to fulfill their objectives, might serve as the cornerstone of your business strategy.

Key objectives of this research are:

To uncover factors influencing the business environment.

To analyze the current Veterinary Vaccines market share, market size, and CAGR

Navigating through opportunities and challenges in the Veterinary Vaccines market.

To measure the impact of marketing, supply chain, and production strategies.

To gauge consumer behavior to better delivery of products.

To know pioneer profit and identify lucrative growth segments.

What are the Perks for Buyers of this Report?

Cost analysis and performance by regions, customers, and products

Insights on developments in foreign markets, competitor moves, technological changes

Regional market insights for investors

Competitive Analysis

Access to PDF, and PPT formats of this research.

Consultation and customization

Veterinary Vaccines Market Segmentation

Based on Vaccine Type of Veterinary Vaccines Market Research report:

Bovine Vaccines

Small Ruminant Vaccines

Based on Companion Animal Vaccines of Veterinary Vaccines Market Research report:

Feline Vaccines

Canine Vaccines

Others

Based on Technology of Veterinary Vaccines Market Research report:

Live Attenuated Vaccines

Inactivated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Conjugate Vaccines

Based on Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World…

[nitasonwane]

Veterinary Consumables Market 2023 Share, Size and Industry Growth

Veterinary consumables refer to a wide range of essential supplies and materials used by veterinarians, veterinary technicians, and other animal healthcare professionals in the course of providing medical care and services to animals. These consumables are used in veterinary clinics, animal hospitals, research laboratories, and other veterinary settings. They are typically disposable items that are used once or for a limited number of times before being discarded.

The global veterinary consumables market size was USD 1.63 billion in 2020. The market is projected to grow from USD 1.71 billion in 2021 to USD 2.83 billion by 2028 at a CAGR of 7.4% in the 2021-2028 period.

List of Key Companies Operating in Veterinary Consumables Market:

Avante Animal Health (Louisville, U.S.)

Midmark Corporation (Dayton, U.S.)

Smiths Medical (Minneapolis, U.S.)

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, China)

B. Braun Melsungen AG (Melsungen, Germany)

VETLAND MEDICAL SALES & SERVICES (Louisville, U.S.)

SunTech Medical, Inc. (Morrisville, U.S.)

Common examples of veterinary consumables include:

Syringes and Needles: Used for administering medications, vaccines, or extracting bodily fluids for diagnostic purposes.

Surgical Instruments: Instruments used in various veterinary surgeries, such as forceps, scalpels, scissors, and retractors.

Medical Gloves: Disposable gloves worn by veterinary professionals to maintain a sterile and hygienic environment and protect against the transmission of pathogens.

Bandages and Dressings: Used to dress wounds, support injured limbs, and promote healing in animals.

Catheters and Intravenous (IV) Sets: Used for administering fluids, medications, or nutrients directly into an animal's bloodstream.

What is the goal of the report?

The market report presents the estimated size of the Veterinary Consumables Market at the end of the forecast period. The report also examines historical and current market sizes.

During the forecast period, the report analyzes the growth rate, market size, and market valuation.

The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa markets.

The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance.

Furthermore, a detailed study of the competitive landscape of the Global Veterinary Consumables Market has been given, presenting insights into the company profiles, financial status, recent developments, mergers and acquisitions, and the SWOT analysis. This research report will give a clear idea to readers about the overall Global Veterinary Consumables Market scenario to further decide on this market project.

Geography Analysis

By region, the global Veterinary Consumables Market is segmented into North America, South America, Europe, Asia-Pacific (APAC), South Africa, Middle East and Africa (MEA). The North America is further classified into U.S., Canada and Mexico. South America is segmented into Peru, Brazil, Argentina, Europe is further segmented into Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland. Asia-Pacific is segmented into China, Japan, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam. MEA is segmented into South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa. Currently, North America dominates the global Veterinary Consumables Market.

[healthcaremarketfmi]

The Middle East Veterinary Vaccines Market Growth Analysis, Outlook by – Trends, Opportunities and Forecast to 2031

According to a recent study by Future Market Insights (FMI), the Middle East Veterinary Vaccines Market is expected to witness moderate growth during the forecast period. The market is expected to grow from US$ 335.0 Mn in 2021 to over US$ 533.4 Mn by 2031. This reflects a cumulative CAGR of around 4.8% over the forecast period (2021-2031).

The demand for veterinary vaccines has increased over the past few years due to the increasing incidences of foodborne and zoonotic infections amongst the population in the Middle Eastern region. The pattern of veterinary treatment is shifting from curative/reactive to preventive in these countries. The cost of preventive treatment is much smaller and has far fewer side effects than reactive treatments that often lead to mass slaughter.

The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt and KSA.

Rising per capita disposable income levels are largely contributing towards demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.

The key players of the veterinary vaccines industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favourable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey and Jordan. These techniques include next-generation sequencing, synthetic biology and systems biology, among others.

Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten time-to-market for upcoming veterinary vaccines.

Key players are working on innovative products, conducting acquisitions, mergers, agreements with other companies to improve their market presence and tap into less competitive emerging markets.

For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for the Rabies Control, as an effort of recognition of World Rabies Day on September 28th.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

Key Takeaways from Middle East Veterinary Vaccines Study

The attenuated live vaccines accounted for 35.1% share of the total market of veterinary vaccines in the Middle East in 2021. The demand for attenuated live vaccines is expected to grow at a CAGR of 5.8% over the forecast period. By triggering a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccinations.

The livestock animals held the maximum share of 73.9% of the total veterinary vaccines market in terms of animal in 2021. Increased demand for processed meat products and making animal health a critical component of disease control is leading to increasing adoption of livestock animal’s vaccination in the Middle Eastern region.

The foot and mouth disease accounted for more than 27% of the market share of the Middle East veterinary vaccines market in 2021. Foot and mouth disease is the most commonly occurring disease amongst all the animals. This segment is expected to project a cumulative CAGR of 5.6% over the forecast period.

The private veterinary pharmacies registered sales worth U.S. $ 114.6 Mn during the year 2021 and are expected to project a cumulative CAGR of 5.0% over the forecast period. Increased awareness regarding animal vaccinations, rising incidences of foot and mouth disease and high demand for good quality processed meat are some of the factors contributing to the growth of private veterinary pharmacies in the Middle East.

“Increased demand for processed meat products around the world will drive the demand for veterinary vaccines market in the Middle East,” says the FMI Analyst.

For More Information: https://www.futuremarketinsights.com/reports/middle-east-veterinary-vaccines-market

Who is winning?

The key manufacturers of the veterinary vaccines market are adopting strategies such as partnership strategies for global expansion and improving their hold over the global market.

In January 2021, Merck Animal Health announced the acquisition of Poultry Sense Ltd, which provides health and environmental monitoring solutions for the poultry industry.

In September 2019, Ceva, in partnership with Biotecon diagnostics, announced the launch of their latest product, a real-time diagnostic kit that will help the poultry producers to fight salmonella infections in their farms.

The key market players of the Middle East veterinary vaccines market include JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The Middle East veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the Middle East veterinary vaccines market. The veterinary vaccines market is segmented into five parts based on vaccine type (attenuated live vaccines, inactivated vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines, and others) based on animal type (companion animals, livestock animals and equine) based on disease indication (foot and mouth disease, NewCastle disease, PPRS, canine parvovirus, brucellosis, avian influenza, and others), based on end-user (hospital pharmacies, veterinary clinics, private veterinary pharmacies and others) and based on country ( KSA, UAE, Turkey, Jordan, Sudan, Egypt and Rest of MEA).

[desaletushki]

Veterinary Hospitals Market Size, Share, Trends And Forecast 2030

The global veterinary hospitals market size is expected to reach USD 125.07 billion by 2030, registering a CAGR of 5.7% over the forecast period, according to a new report by Grand View Research, Inc. Boom in pet population is driving the market growth. As per the American Veterinary Medical Association, over the next 10 years, the number of dogs and cats in the U.S. is anticipated to increase substantially. The dog populace is likely to rise from 85 million in 2020 to over 100 million by 2030. While cat populace is likely to surge even more intensely, from 65 million to more than 82 million. This upsurge in the pet population will drive the market. Despite the difficulties and new ways of working formed by the COVID-19 pandemic, for numerous hospitals, client numbers are growing.

Free Sample Report: https://www.grandviewresearch.com/industry-analysis/veterinary-hospitals-market-report

In addition, veterinary practice activity in the U.S. has fluctuated, but in general, the demand remains high. According to the Veterinary Industry Tracker, revenue per practice was up 13.3% year-over-year (November 2020 to November 2021). Client visits were up 5.1% during the same period. In numerous households across the globe, pets are seen as a core member of the family. There is a growing trend of pet humanization, resulting in an increased average spend on pet healthcare. Thus, pet humanization is set to drive the sales of veterinary services. This trend will be led by the growing population of small animals along with economic growth in developing markets. Improvements in technology have advanced veterinary care.

Technology is becoming more affordable and more practices around the world can adopt MRI and CT scanners. Digital dental X-rays and innovative oral surgery instruments are allowing veterinarians to advance in oral care in companion animals. Constant developments further address health issues in pets not just within hospitals, but on an all-around basis for better care and prevention. Access to veterinary healthcare is relatively underprivileged in most developing countries and some developed nations. For instance, according to a survey conducted in 2020 by the Federation of Veterinarians of Europe, rural and remote areas of Ireland have a shortage of veterinarians. Similarly, England is also experiencing a shortage of veterinarians in rural areas. This may restrict the market growth to some extent.

Veterinary Hospitals Market Report Highlights

In terms of revenue, the medicine segment dominated the market in 2021. The high demand for animal products, such as chicken and milk, is encouraging farmers to adopt vaccinations for their animals to gain higher profitability

The surgery type segment is estimated to register lucrative CAGR over the forecast period due to the growing pet insurance & healthcare expenditure and rising cases of chronic diseases in pets

Companion animals dominated the animal type segment in 2021 due to the growing trend of pet humanization

The private sector segment led the market in 2021 due to the growing disposable income and willingness to pay premium prices for veterinary services among owners

Asia Pacific is expected to witness a lucrative CAGR over the forecast period owing to the increased vigilance about animal health and rapid urbanization

In February 2020, DCC (Dogs Cats & Companions) Animal Hospital announced the launch of a series of multi-specialty animal hospitals across India. These hospitals will be advanced and equipped with innovative infrastructure and medical expertise

Industry players are involved in strategic initiatives, such as business expansion, M&As, and geographic expansion to gain higher market shares

For instance, in June 2021, CVS Group announced the establishment of a new state-of-the-art specialist veterinary hospital in Bristol, which will open in 2022, with modern technology and treatments in all disciplines

Key Companies & Market Share Insights

The hospitals are constantly involved in strategic initiatives, such as regional expansion, mergers, acquisitions, and new service launches, to gain a higher market share. For instance, in February 2021, the CVS group announced the purchase of the Market Hall Vets, a first opinion practice functioning three locations across Carmarthenshire in southwest Wales. In May 2020, Greencross Vets introduced WebVet a 24/7 online consultation service. Thus, enhanced its service offering to Australia’s network of 1000 veterinary professionals. Some of the prominent players in the global veterinary hospitals market include: CVS Group PLC, Greencross Vets, Ethos Veterinary Health, Pets At Home Group PLC, Mars, Animal Hospital Inc., All Pets Animal Hospital, Cahaba Valley Animal Clinic, Blaine Central Veterinary Clinic, Belltowne Veterinary Center

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/veterinary-hospitals-market-report

[kudos12]

Research Nester recently published a report titled “Global Pet Veterinary Drugs Market Outlook: Industry Analysis & Opportunity Evaluation 2019-2025” which delivers detailed overview of the global pet veterinary drugs market in terms of market segmentation by drug, route of administration, composition, end-user, and by regions.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Bayer AG has acquired numerous companies in order to increase its overall marginal revenue in the market. The company has gone through various acquisitions in the recent past such as, Covestro, Monsanto and others in order to expand its product portfolio as well as to increase its net revenue.

The global pet veterinary drugs market is significantly driven by the rising expenses on pets by the owners. As the demand for pet veterinary drugs increases, the size of the global pet veterinary drugs market holds a market revenue of USD 16,239.3 Million in 2018. Pet veterinary drugs offered by numerous veterinary care centers are encouraging the concerns among people for their pets and routine checkups. The rise in number of visits for routine care in veterinary or clinic house calls i.e. 67% of dogs and 40.6% of cats in 2016 is anticipated to foster the demand for pet veterinary drugs market during the forecast period. It is estimated to expand robustly at a CAGR of 3.9% over the forecast period, i.e., 2019-2025.

Request Sample on Pet Veterinary Drugs Market Report @ https://www.researchnester.com/sample-request-1808

On the basis of geography, the global pet veterinary drugs market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The market in North America was estimated to hold highest market share of 38.1% in 2018. The growth in the region can be attributed to the growing pet expenditure. Re-occurrence of animal diseases is also expected to drive the growth of the market in North America, with the U.S. being the prominent market driving the growth in the region.

Several factors such as rapidly increasing pet adoptions is also expected to propel the market growth. As per APPA, in the year 2016, approximately 78 million dogs and 85.8 million cats were domesticated in the United States. Similarly, the market in Europe is expected to expand for pet veterinary drugs on the back of increasing dog and cat population in the region, particularly in the U.K, Russia, France, Germany, and Spain. Additionally, there is a high rate of adoption of cats and dogs among other pets, which is enhancing the demand for drugs given to dogs and cats as compared to other veterinary drugs in the market.

Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/pet-veterinary-drugs-market/1808

The global pet veterinary drugs market has been segmented by drugs into pharmaceuticals & biologics and vaccines. Among these segments, Pharmaceuticals & Biologics segment held the larger market share of 71.4% share in 2018. Similarly, on the basis of composition, the market is segmented into anti-infectives, anti-inflammatory, parasiticides, analgesics & sedatives and others. Out of which, the parasiticides segment held the largest share in the year 2018.

The growth of the market may be impeded by a few factors, which includes high costs associated with veterinary drugs and therapies. In addition, lack of routine checkups and preventive measures for pets in numerous households, across the globe, is also expected to restrain the market demand for pet veterinary drugs. Furthermore, lack of research and development in veterinary drug segment coupled with lack of attention by government is creating huge gap between affordability of drugs and the pet care.

Request a sample Report of Pet Veterinary Drugs Market @ https://www.researchnester.com/sample-request-1808

This report also provides the existing competitive scenario of some of the key players of the global pet veterinary drugs market which includes company profiling of Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation,and other prominent players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global pet veterinary drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

—————- Read More Market Related Reports——————— 

Flexible Plastic Packaging Market BioFertilizers Market United States Hydroponics Market Aloe Vera Extract Market Military Robots Market

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact Us

AJ Daniel Email: info@researchnester.com U.S. Phone: [+1 646 586 9123] U.K. Phone: [+44 203 608 591]

[bigfandeer]

Global Veterinary imaging Market Size By Vaccine Type, By Technology, By Geographic Scope And Forecast 2025

The global veterinary imaging market, as per the reports of Market Research Future (MRFR), can eye for an impressive CAGR of 7.14% over the review period (2016-2025). The time-span can also witness a surpassing of the predicted market valuation of USD 1800 million by the global veterinary imaging market. Veterinary imaging is the technology that provides a detailed report about diseases that pets or animals have. The global veterinary imaging market is all geared to profit much from advanced technologies that the market titans are launching.

Factors that can trigger market growth are cost-effective procedures, rising instances of pets getting covered by insurance policies, increasing disposable income, and surge in the ownership of pets across the world. Intensive animal farming can also impact the veterinary imaging market in the coming years.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2919

Market Segmentation:

By type, the global veterinary imaging market has been segmented into veterinary imaging instruments, veterinary imaging reagents, and veterinary imaging software.

By product type, the market for veterinary imaging is segmented into large animals, small companion animals, and others.

By therapeutic area, the global veterinary imaging market has been segmented into orthopedics and traumatology, cardiology, neurology, and, oncology.

By end-user, the market for veterinary imaging market is segmented into hospitals & clinics, and, academic institutes.

Regional Analysis

Europe, Asia Pacific (APAC), the Americas, and the Middle East & Africa (MEA) are region considered during the compilation of the global veterinary imaging market report.

The Americas accounted for the largest market share in 2018. It is predicted to exhibit 7.62% CAGR during the forecast period due to rise in pet ownership rates, demand for pet insurance, increase in veterinary expenditure. This is supported by statistics by the American Pet Products Association which stated nearly 68% of pet owners in the U.S. accounting for a pet in their household.

Europe is the second biggest region due to presence of veterinary clinics, advanced diagnostic procedures, and rise in pet ownership. On the other hand, the APAC region is driven by rise of nuclear families, large expendable income levels, and adoption of pets.

The MEA market can face a sluggish growth rate during the forecast period due to low production rate of purebreds and low investments by the pet care sector.

Competitive Landscape:

MRFR includes several companies that would influence the veterinary imaging market in the coming years. They are Hallmarq Veterinary Imaging Ltd, Esaote SpA, Diagnostic Imaging System, Inc, Heska Corporation, General Electric Canon Inc., Merry X-Ray, Medical Imaging / IMCO, Inc, Fujifilm Holding Corporation, Carestream Health, BCF Technology Ltd, and Idexx Laboratories Inc.

In 2019, Sound, a global leader in providing veterinary imaging solutions, teamed up with Canon for their digital radiography detectors and medical SDK. The result is a software, that would provide a seamless, robust, veterinary-specific digital radiography system.

List Of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 LIST OF ASSUMPTIONS 19

TABLE 3 GLOBAL VETERINARY IMAGING MARKET BY PRODUCT TYPE, 2020-2027 (USD MILLION) 35

TABLE 4 GLOBAL VETERINARY IMAGING INSTRUMENTS MARKET BY REGION, 2020-2027 (USD MILLION) 36

TABLE 5 GLOBAL VETERINARY IMAGING INSTRUMENTS MARKET BY TYPE, 2020-2027 (USD MILLION) 36

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[allthebrazilianpolitics]

Brazil Veterinary Vaccines Market Analysis - COVID-19 Impact, Outlook, Opportunities, Size, Share Forecast and Supply Demand 2021-2027

The Brazil veterinary vaccines market size was valued at USD 324.2 million in 2020 and is expected to register a compound annual growth rate (CAGR) of 5.3% from 2021 to 2027. Rising mandates for vaccination to curb livestock disease outbreaks and increasing demand for livestock-related food products are primary factors expected to drive market growth. The country ranked second in broiler meat production followed by the U.S. in 2019. The massive outbreak of COVID-19 in livestock producing countries, such as China and the U.S., is expected to increase Brazils meat export market. For instance, Brazilian livestock production is expected to increase by nearly 5% in 2020 due to COVID-19 pandemic.

Favorable government initiatives are likely to boost revenue growth. For instance, in May 2018, the World Organization for Animal Health declared Brazil, free of foot and mouth disease (FMD) with vaccination. The National Program for the Eradication and Prevention of FMD reduced the disease vaccine dose from 5 mL to 2 mL and aims to totally withdraw the vaccine by 2021.

Increasing companion animal population is further boosting the market growth. According to Abinpet report, there were around 52 million dogs in Brazil, highest in Latin America. Moreover, increasing trend of animal-assisted therapies is propelling the market growth. People with attention deficit disorder, autism spectrum disorder, Cerebral Vascular Accident (CVA) have reported benefits from animal-assisted therapies. The growing concern regarding pet health is further boosting the vaccine market.

Continue reading.

[balrajgis]

Veterinary Vaccines Market SWOT analysis, Growth, Share, Size and Demand outlook by 2031 | Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A.

Global Veterinary Vaccines Market report from Global Insight Services is the single authoritative source of intelligence on Veterinary Vaccines Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Veterinary vaccines are products used to stimulate an animal’s immune system to produce immunity against a specific disease. Vaccines are typically composed of one or more viruses, bacteria, or other microorganisms that have been modified or killed in order to reduce or eliminate their pathogenicity, and/or toxoids which are toxins that have been rendered harmless. Vaccines may also contain adjuvants, which are substances that are added to the vaccine to improve its efficacy.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS22299/

Key Trends

The key trends in Veterinary Vaccines technology are:

1. The development of safer and more effective vaccines

2. The use of new technologies to improve vaccine efficacy

3. The development of new delivery systems for vaccines

Key Drivers

The key drivers of the veterinary vaccines market are the increasing demand for animal-derived products, the growing awareness of the importance of animal health, and the government support for the development of the veterinary vaccines industry. The other drivers include the technological advances in vaccine production and the increasing number of pet ownership. The demand for animal-derived products is increasing due to the growing population and the changing lifestyle. People are becoming more health-conscious and are demanding healthy and nutritious food.

Market Segments

By Product

Attenuated Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

By Animal Type

Companion Animal

Livestock Animal

By Region

North AmericaThe U.S.

Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS22299

Key Players

Merck & Co., Inc.

Zoetis Inc.

Ceva Santé Animale

Sanofi S.A.

Romvac

Vaxxinova

Biovac

Merial

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[industryrecentdevelopment]

Veterinary Patient Monitoring Equipment Market Analysis Market Size

The Veterinary Patient Monitoring Equipment Market will change significantly from the previous year. Over the next five years, will register a CAGR in terms of revenue, and the global market size will reach USD in millions by 2028.

The veterinary patient monitoring equipment market consists of the sale of veterinary patient monitoring equipment which is used to monitor animals' respiration, blood pressure, and other vital signs. Veterinary patient monitoring equipment is used to monitor the animals to detect diseases at early stages to prevent any risks. The veterinary patient monitoring equipment industry includes companies that manufacture monitoring devices to detect diseases that affect animals.

The global Veterinary Patient Monitoring Equipment Market is segmented based on product type, end user, and geography. Based on product type, it is classified into 5-axis, 4-axis, and 3-axis. Based on end users, it is categorized into dental, medical, and orthopedic. By geography, it is analyzed across North America, Europe, Asia-Pacific, and south America.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

   The Major Players in the Veterinary Patient Monitoring Equipment Market Include:

Bionet America,Smiths,Hallowell Engineering & Manufacturing,DRE Veterinary,Digicare Biomedical Technology,Midmark,Hallmarq Veterinary Imaging,EsaoteS.p.A,MinXray,Agfa Healthcare,IDEXX Laboratories,Carestream Health,Medtronic,B. Braun Vet Care,GE Healthcare

Request a free sample copy or view the report summary @:

https://introspectivemarketresearch.com/request/10001

Market has segmented the global Veterinary Patient Monitoring Equipment market on the basis of type, application, and region:

By Type:

·         Cardiac Monitoring Devices

·         Respiratory Monitoring Devices

·         Remote Veterinary Patient Monitoring Devices

·         Multi-parameter Monitoring Devices

·         Neuromonitoring Devices

·         Others

By Application:

·         Veterinary Hospitals

·         Veterinary Clinics

·         Veterinary Research Centers

By Regional Outlook (Revenue, USD Billion, 2017 – 2028)

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)

Middle East & Africa (GCC Countries, South Africa, Rest of MEA)

South America (Brazil, Argentina, Rest of South America)

Get a Discount on This Report @:

https://introspectivemarketresearch.com/discount/10001

The Veterinary Patient Monitoring Equipment market is segmented by type and application. Growth between segments over the period 2022-2028 provides accurate calculations and forecasts of revenue by type and application in terms of volume and value. This analysis can help you expand your business by targeting eligible niches.

Covid-19 Impact and Recovery Analysis on Industry:

The COVID-19 pandemic has had devastating effects on several industry verticals globally. To constrain the number of cases and slow the coronavirus spread, various public health guidelines were implemented in different countries across the globe. COVID-19 protocols ranging from declaring national emergency states, enforcing stay-at-home orders, closing nonessential business operations and schools, banning public gatherings, imposing curfews, distributing digital passes, and allowing police to restrict citizen movements within a country, as well as closing international borders. With the growing vaccination rate, governments are uplifting the protocols to give a boost to the stagnant economy. Like other industries, Veterinary Patient Monitoring Equipment Market have experienced slowdown the growth, however market is expected bounce back as restrictions are being lifted up by governments across the globe.

Enquire before purchasing this report@:

https://introspectivemarketresearch.com/inquiry/10001

Key Reasons to Purchase:

·         Gained an analysis of market insights and a comprehensive understanding of the Global Veterinary Patient Monitoring Equipment Market and commercial environment.

·         To mitigate development risk, the production process evaluates key problems and solutions.

·         Recognize the driving forces and impediments that have the biggest influence on covid-19 in the Veterinary Patient Monitoring Equipment market, as well as its worldwide market.

·         Explains the market strategies adopted by each major institution.

·         Understand the Veterinary Patient Monitoring Equipment Market's future view and forecast.

·         In addition to standard structure reports, we also offer custom studies tailored to specific requirements.

Purchase This Report: - https://introspectivemarketresearch.com/reports/veterinary-patient-monitoring-equipment-market/

Browse IMR News: -

https://www.openpr.com/news/2648286/gaming-market-size-share-covid-19-impact-analysis-by-type

https://www.digitaljournal.com/pr/law-enforcement-software-market-size-share-forecasts-trends-analysis-report-with-covid-19-impact-by-introspective-market-research

https://www.digitaljournal.com/pr/ammonium-thiosulfate-market-industry-analysis-and-forecast-2022-2028-by-type-and-application

https://www.digitaljournal.com/pr/smart-shopping-cart-market-research-report-by-technology-mode-of-sales-application-region-global-forecast-to-2028-report-by-introspective-market-research